Target intelligence / Profile preview

Protein secretion Sec translocation machinery (Sec machinery (SecYEG complex in bacteria; Sec61 complex in eukaryotes))

Target
Sec machinery (SecYEG complex in bacteria; Sec61 complex in eukaryotes)
Molecular classification
Transporter (protein-conducting channel), Enzyme (SecA is a motor ATPase component), Other: Multimeric translocase complex
01

Overview

The Protein secretion Sec translocation machinery is a highly conserved protein complex that mediates the export of unfolded polypeptides across cellular or organellar membranes. In bacteria, it consists primarily of the SecYEG channel and the SecA ATPase motor, which threads proteins through a membrane pore using ATP hydrolysis and the proton gradient as energy sources. Precursor proteins are directed to the complex by N-terminal signal sequences, kept unfolded by chaperones (such as SecB), and translocated through SecYEG (bacteria) or Sec61 (eukaryotes), either post-translationally or co-translationally. This machinery is essential for bacterial viability and the secretion of pathogenic factors, representing an attractive target for new classes of antibiotics.

Other names
Sec translocaseSecYEG complex (bacteria)SecA-SecY complex (bacteria)Sec61 complex (eukaryotes)Protein-conducting channelSec system
02

Mechanism of action

Inhibition of SecA ATPase activity (blocks energy-dependent translocation); Disruption of SecYEG complex function (prevents protein export and cell wall protein localization)

03

Biological functions

Protein translocation across membranesSecretion of proteinsMembrane protein integration
04

Disease associations

Infection (essential for bacterial viability and pathogenicity)Other: Potential indirect roles in immune response and antibiotic resistance due to effects on secreted factors
05

Safety considerations

Targeting bacterial Sec machinery offers selectivity over human Sec61, but resistance mutations may arise. Human homologue (Sec61 complex) is essential; off-target effects present risk in eukaryotic systems.
06

Interacting drugs

None presently approved for clinical use, but small molecule inhibitors of SecA have been investigated as antibacterials
07

Biomarkers

None established clinically. Experimental tools may include monitoring secretion of bacterial virulence factors or tagged secretory proteins.

Beyond the preview

Go deeper on Protein secretion Sec translocation machinery (Sec machinery (SecYEG complex in bacteria; Sec61 complex in eukaryotes)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein secretion Sec translocation machinery (Sec machinery (SecYEG complex in bacteria; Sec61 complex in eukaryotes)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call